Bildkälla: Stockfoto

Medivir: MIV-711 Obtains Rare Pediatric Disease Designation and Orphan Drug Designation - Redeye

Redeye sees the RPDD and ODD from the FDA as signs that the osteoarthritis programme MIV-711 is moving forward.

Redeye sees the RPDD and ODD from the FDA as signs that the osteoarthritis programme MIV-711 is moving forward.
Börsvärldens nyhetsbrev
ANNONSER